Groupe Oncologie Radiotherapie Tete Et Cou

This phase 2 trial compares stereotactic radiotherapy alone versus radiotherapy plus chemotherapy for people with head and neck cancer that has spread to 1-3 other spots in the body. The main goal is to see if the combination helps patients live at least one year without a drop i…

This Phase 3 trial tests whether giving a three-drug chemotherapy regimen (docetaxel, cisplatin, and fluorouracil) before radiotherapy helps people with advanced laryngeal or hypopharyngeal cancer avoid losing their voice box. The standard approach is to give cisplatin during rad…